Publikasi

Regulatory Support Helping Biopharma to Embrace Platfor...

Platform technologies that can be reused for the manufacture of multiple drug pr...

Biologics Manufacturers Urged to Develop QC Plans Early

Biologics manufacturers urged to develop a chemistry, manufacturing, and control...

Drugs from the Deep

From cancer therapies to antivirals, ocean-derived drugs hold vast promise—but s...

Framework to Optimize Mammalian Cell Culture Media Blen...

A new workflow transforms media blending into a practical alternative for screen...

Modulating the Secretory Pathway for Enhanced Therapeut...

Avenue uses thousands of naturally occurring and engineered signal peptides to m...

BD invests $110m to expand US prefillable syringe produ...

The company aims to strengthen the pharmaceutical supply chain and accelerate th...

Fortress Biotech receives FDA approval for Zycubo to tr...

Menkes disease is a rare X-linked recessive disorder caused by mutations in the ...

Inside the world of pharma consulting: The career that ...

When a survey by TCS and the Association of Management Consulting Firms reveale...

Our goal is to help companies reduce cost per cubic met...

The pharma industry is considered one of the most polluting industries, not jus...

Beyond the Warehouse Doors: How MVS Pharma Ensures GDP-...

Transportation is a critical extension of pharmaceutical distribution activities...

Amneal unveils new brand to reimagine what’s possible i...

Amneal Pharmaceuticals introduced a bold new brand and visual identity that ref...

Next big leap in Indian pharma’s digital journey, AI-le...

Archimedis Digital, a leading digital transformation partner for life sciences ...

India’s Pharma 2047: How academia can drive innovation ...

As India marches toward its 2047 vision of becoming an innovation-led, self-rel...

Mapping the Next Phase of Analytical Innovation for ADCs

In this Thought Leader piece Li Qu, PhD, and Peng Li, PhD, from WuXi AppTec why ...

Fast-Tracked CGT Platform Eliminates Patient Preconditi...

Immusoft’s autologous immune system programming platform is in the clinic for MP...

Nanoparticles and Beyond: Novel Drug Delivery Strategie...

What innovations will define the cancer drug delivery landscape in 2026? To find...